Physician profile
Michael Mesbah
NPI 1396780276
$1,613.88
in general payments reported to CMS, 2019-2025
21 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $77.39 · 2021: $43.50 · 2022: $302 · 2023: $151 · 2024: $483 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $418.84 | 2019-2023 | |
| Pfizer INC. | $128.59 | 2019-2024 | |
| Aspira Women'S Health INC | $121.94 | 2019-2023 | Ova1 |
| Hologic Sales and Service, LLC | $120.85 | 2024 | Acessa Provu System, Novasure |
| Mimedx Group, INC. | $117.65 | 2024 | |
| Applied Medical Resources Corporation | $109.07 | 2024 | Gelpoint V-Path |
| Mayne Pharma Commercial LLC | $96.76 | 2022-2025 | |
| Astellas Pharma US INC | $85.78 | 2023-2025 | Veozah |
| Amgen INC. | $68.64 | 2019 | |
| Amag Pharmaceuticals, INC. | $57.24 | 2019 | |
| Organon LLC | $47.73 | 2022-2024 | |
| Biogen, INC. | $44.83 | 2024 | |
| Merck Sharp & Dohme LLC | $37.52 | 2024-2025 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $24.65 | 2025 | |
| Evofem Biosciences, INC. | $22.96 | 2025 | Solosec, Phexx, Phexxi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $22.77 | 2022 | |
| Coopersurgical, INC. | $22.65 | 2022 | |
| Allergan, INC. | $20.98 | 2019 | |
| Lupin INC. | $18.14 | 2019 | |
| Exeltis, USA INC. | $16.61 | 2019 | |
| Channel Medsystems, INC. | $9.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mesbah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.